PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 7509985

Age-dependent decrease in endothelium-dependent hyperpolarizations to endothelin-3 in the rat mesenteric artery.

M Nakashima·P M Vanhoutte
View original source ↗Export metadata ↓

Abstract

The present study was designed to investigate the effects of age on the endothelium-dependent hyperpolarizing effect of endothelin-3 (ET-3) in the mesenteric artery of the rat. Main superior mesenteric arteries, with endothelium of young (7-9 weeks), adult (20-24 weeks), and old (40-50 weeks) male Wistar-Kyoto rats were studied. The cell membrane potential of the vascular smooth-muscle cells was measured with glass microelectrodes in the presence of indomethacin (inhibitor of cyclooxygenase) and NG-nitro-L-arginine (NLA, inhibitor of nitric oxide synthase). In preparations with endothelium from young rats, ET-3 produced transient hyperpolarizations in a concentration-dependent (10(-8) to 10(-9) M) manner. In tissues from adult rats, only a small hyperpolarization to the peptide was observed at 10(-7) M, whereas no detectable membrane potential changes were observed in tissues from old animals. In tissues of all groups, acetylcholine produced concentration-dependent hyperpolarizations, the maximal amplitude of hyperpolarization was reduced in the old rats but no significant differences were observed in the threshold concentration for hyperpolarization to acetylcholine. These data suggest that aging decreases endothelium-dependent hyperpolarizations evoked by both ET-3 and acetylcholine.

Explore related subjects

AcetylcholineAgingAnimalsArginineEndothelinsEndothelium, VascularIn Vitro TechniquesIndomethacinMaleMembrane PotentialsMesenteric ArteriesMuscle, Smooth, VascularNitroarginineRatsRats, Inbred WKYJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Nakashima, P M Vanhoutte. 1993. Age-dependent decrease in endothelium-dependent hyperpolarizations to endothelin-3 in the rat mesenteric artery.. https://doi.org/10.1097/00005344-199322008-00092

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1998

Age-related changes in neuronal nicotinic acetylcholine receptor subunit alpha4 expression are modified by long-term nicotine administration.

The distribution of the neuronal nicotinic acetylcholine receptor subunit alpha4 (nAChRalpha4) in the brains of young (2-4 months) or aged (24-28 months) CBA/J mice was examined using immunohistochemical staining. Anti-nAChRalpha4 immunoreactivity corresponded with nAChRalpha4 RNA expression and high-affinity [3H]nicotine binding. Immunostaining in aged mice relative to that in young animals was diminished in the medial septum and diagonal band but was unchanged in the globus pallidus and substantia nigra. The staining of neurons was almost completely absent in the hippocampus of aged animals. The oral administration of nicotine to aged animals for 6 weeks did not alter nAChRalpha4 expression relative to that in aged controls. However, the long-term delivery of nicotine (11 months) to 14-month-old animals corresponded with the highly specific preservation of nAChRalpha4 expression in some neurons of the dentate gyrus region and in neurite processes of remaining neurons of the hippocampal CA1 region. These results support the conclusion that the loss of nAChRalpha4 expression occurs in key cholinergic regions during normal aging. Furthermore, sustained long-term nicotine delivery may promote highly region-specific retention of nAChR expression, but only if initiated before normal age-related receptor decline.

Acetylcholine↗
PubMed1998

Ca2+ channel beta3 subunit enhances voltage-dependent relief of G-protein inhibition induced by muscarinic receptor activation and Gbetagamma.

The Ca2+ channel beta subunit has been shown to reduce the magnitude of G-protein inhibition of Ca2+ channels. However, neither the specificity of this action to different forms of G-protein inhibition nor the mechanism underlying this reduction in response is known. We have reported previously that coexpression of the Ca2+ channel beta3 subunit causes M2 muscarinic receptor-mediated inhibition of alpha1B Ca2+ currents to become more voltage-dependent. We report here that the beta3 subunit increases the rate of relief of inhibition produced by a depolarizing prepulse and also shifts the voltage dependency of this relief to more hyperpolarized voltages; these effects are likely to be responsible for the reduction of inhibitory response of alpha1B channels to G-protein-mediated inhibition seen after coexpression of the Ca2+ channel beta3 subunit. Additionally, the beta3 subunit alters the rate and voltage dependency of relief of the inhibition produced by coexpressed Gbeta1gamma1, in a manner similar to the changes it produces in relief of M2 receptor-induced inhibition. We conclude that the Ca2+ channel beta3 subunit reduces the magnitude of G-protein inhibition of alpha1B Ca2+ channels by enhancing the rate of dissociation of the G-protein betagamma subunit from the Ca2+ channel alpha1B subunit.

Acetylcholine↗
PubMed1998

Coadministration of galanin antagonist M40 with a muscarinic M1 agonist improves delayed nonmatching to position choice accuracy in rats with cholinergic lesions.

The neuropeptide galanin is overexpressed in the basal forebrain in Alzheimer's disease (AD). In rats, galanin inhibits evoked hippocampal acetylcholine release and impairs performance on several memory tasks, including delayed nonmatching to position (DNMTP). Galanin(1-13)-Pro2-(Ala-Leu)2-Ala-NH2 (M40), a peptidergic galanin receptor ligand, has been shown to block galanin-induced impairment on DNMTP in rats. M40 injected alone, however, does not improve DNMTP choice accuracy deficits in rats with selective cholinergic immunotoxic lesions of the basal forebrain. The present experiments used a strategy of combining M40 with an M1 cholinergic agonist in rats lesioned with the cholinergic immunotoxin 192IgG-saporin. Coadministration of intraventricular M40 with intraperitoneal 3-(3-S-n-pentyl-1,2,5-thiadiazol-4-yl)-1,2,5, 6-tetrahydro-1-methylpyridine (TZTP), an M1 agonist, improved choice accuracy significantly more than a threshold dose of TZTP alone. These results suggest that a galanin antagonist may enhance the efficacy of cholinergic treatments for the cognitive deficits of AD.

Acetylcholine↗